WallStSmart

Covista Inc. (CVSA)vsUniversal Technical Institute Inc (UTI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 121% more annual revenue ($1.95B vs $883.60M). CVSA leads profitability with a 12.9% profit margin vs 3.9%. CVSA appears more attractively valued with a PEG of 0.98. CVSA earns a higher WallStSmart Score of 68/100 (B-).

CVSA

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.5Value: 7.0Quality: 6.5
Piotroski: 4/9Altman Z: 3.05

UTI

Hold

44

out of 100

Grade: D

Growth: 6.0Profit: 5.0Value: 3.3Quality: 5.0
Piotroski: 5/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CVSA.

UTISignificantly Overvalued (-22.2%)

Margin of Safety

-22.2%

Fair Value

$22.22

Current Price

$20.31

$1.91 premium

UndervaluedFair: $22.22Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA5 strengths · Avg: 8.4/10
Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.988/10

Growing faster than its price suggests

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

EPS GrowthGrowth
43.2%8/10

Earnings expanding 43.2% YoY

UTI0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CVSA0 concerns · Avg: 0/10

No major concerns identified

UTI4 concerns · Avg: 3.8/10
PEG RatioValuation
1.924/10

Expensive relative to growth rate

P/E RatioValuation
34.9x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Market CapQuality
$1.17B3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. PEG of 0.98 suggests the stock is reasonably priced for its growth.

Bull Case : UTI

UTI has a balanced fundamental profile.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Bear Case : UTI

The primary concerns for UTI are PEG Ratio, P/E Ratio, Altman Z-Score. Thin 3.9% margins leave little buffer for downturns.

Key Dynamics to Monitor

UTI carries more volatility with a beta of 1.17 — expect wider price swings.

CVSA is growing revenue faster at 9.7% — sustainability is the question.

CVSA generates stronger free cash flow (97M), providing more financial flexibility.

Monitor EDUCATION & TRAINING SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CVSA scores higher overall (68/100 vs 44/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Universal Technical Institute Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Universal Technical Institute, Inc. offers postsecondary education for students seeking careers as professional automotive, diesel, collision repair, motorcycle and marine technicians in the United States. The company is headquartered in Phoenix, Arizona.

Want to dig deeper into these stocks?